Can a simple plan keep schizophrenia patients out of the hospital?
NCT ID NCT02627716
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a personalized crisis plan, called the SOS Plan, could reduce hospitalizations in people with schizophrenia or schizoaffective disorder. 124 patients worked with their doctors and loved ones to create a plan outlining what to do in a crisis. The goal was to see if this plan, updated every 6 months, would lead to fewer psychiatric hospitalizations over 18 months compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- SOS Plan (joint crisis plan)
- What this could lead to
- If effective, the SOS Plan could become a standard tool to help people with schizophrenia avoid repeated hospitalizations and stay stable longer.
- What could go wrong
- This is a small, completed trial with 124 participants. The plan may not work for everyone, and results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
124 people
The number who actually took part.
- Started
-
Dec 2014
- Finished
-
Mar 2016
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged between 18 and 65 years * Diagnosed with schizophrenia or schizoaffective disorder according to criteria specified in DSM * Psychiatric inpatient or an outpatient with a specialised framework of psychiatric follow-ups * Patient has been hospitalised at least once in a psychiatric department within the previous 2 years * Adults under protective measures can be included (guardianship/supervision). Consent will also be sought from the guardian or trusted person. * Registered for social security Exclusion Criteria: * Refusal to participate in the study * Unable to give his or her written consent * Patients detained * Pregnant or lactating women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Schizoaffective disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sainte-Anne Hospital, Paris
Paris, France
-
University Hosiptal, Lille
Lille, France
-
University Hospital, Brest
Brest, France
-
University Hospital, Caen
Caen, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may reveal if You're taking your psychiatric medication
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug